  The manuscript deals with personalized medicine and medical liability in Europe and Italy , addressing the importance of synergistic collaboration between clinical and medico-legal professionals in order to appropriately investigate medical errors and prevent any future adverse event. Following a rapid epidemiological overview of mala praxis in Europe , the manuscript presents and discusses the International Guidelines developed and adopted by the International Academy of Legal Medicine ( IALM) , which guide the work of the medical experts under both criminal and/or civil law. Finally , the manuscript proposes the indispensability of a quality assurance and accreditation system for clinical and medico-legal reports along with a shared and integrated methodology for managing health claims in order to prevent adverse events.